TerminatedPHASE1, PHASE2NCT02025881
Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma
Studying Medulloblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Principal Investigator
- Christelle Dufour, MDGustave Roussy, Cancer Campus, Grand Paris
- Intervention
- Carboplatin + etoposide(drug)
- Enrollment
- 29 target
- Eligibility
- 5 years · All sexes
- Timeline
- 2013 – 2020
Study locations (13)
- Gustave Roussy, Villejuif, Val De Marne, France
- Institut de Cancérologie de l'Ouest (ICO) - Site Paul Papin, Angers, France
- Centre Oscar Lambret, Lille, France
- Centre Léon Bérard, Lyon, France
- CHU La Timone, Marseille, France
- CHU Arnaud de Villeneuve, Montpellier, France
- CHU Nancy Brabois, Nancy, France
- CHU de Nice - Hôpital L'Archet 2, Nice, France
- Institut Curie, Paris, France
- Hôpital Américain, Reims, France
- CHU Hôpital Sud, Rennes, France
- CHRU Hautepierre, Strasbourg, France
- Hôpital des enfants, Toulouse, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02025881 on ClinicalTrials.govOther trials for Medulloblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07085325CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal IrradiationSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT06701812Digoxin Medulloblastoma StudyH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNANCT06898684Medulloblastoma Online Video-based Exercise Pilot StudyAron Onerup
- RECRUITINGNCT07242963Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyMohammad H. Abu Arja
- RECRUITINGEARLY PHASE1NCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- ACTIVE NOT RECRUITINGPHASE1NCT06514898Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With MedulloblastomaUniversity of Florida
- RECRUITINGNCT06779487Systemic Biomarkers to Predict Radiation-Induced Neurocognitive DeclineTata Memorial Centre
- RECRUITINGEARLY PHASE1NCT06959979Novel Molecular Targets and Innovative Therapeutic Perspective in MedulloblastomaFondazione Policlinico Universitario Agostino Gemelli IRCCS